Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model

Clinical and Experimental Metastasis

Volumn 29, Issue 3, 2012, Pages 229-238

  Ozaki, Hidenori ^a   Matsuzaki, Hideki ^a   Ando, Hidenobu ^a,b   Kaji, Hiroyuki ^a   Nakanishi, Hayao ^c   Ikehara, Yuzuru ^a   Narimatsu, Hisashi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b GlycoGene Inc   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CD44; Gastric cancer; Glycoprotein; Mouse; MUC1; Peritoneal metastasis; Sialyl Tn; ST6GalNAcI

Indexed keywords

CARRIER PROTEIN; HERMES ANTIGEN; MONOCLONAL ANTIBODY; MUCIN 1; SIALYL TN ANTIGEN; SIALYLTRANSFERASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER TRANSPLANTATION; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PERITONEUM METASTASIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; SUPERNATANT; SURVIVAL TIME;

ANIMALS; ANTIGENS, CD44; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MUCIN-1; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SIALYLTRANSFERASES; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84857366326     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9445-1     Document Type: Article

References (47)

1. JL Werther S Rivera-MacMurray H Bruckner, et al. 1994 Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome Br J Cancer 69 3 613 616 8123499 10.1038/bjc.1994.114 1:STN:280:DyaK2c7mvV2rsg%3D%3D (Pubitemid 24076492)
2. JL Werther M Tatematsu R Klein, et al. 1996 Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study Int J Cancer 69 3 193 199 8682587 10.1002/(SICI)1097-0215(19960621)69:3<193::AID-IJC8>3.0. CO;2-V 1:STN:280:DyaK283ms1Cmuw%3D%3D (Pubitemid 26233298)
3. XC Ma N Terata M Kodama, et al. 1993 Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas Eur J Cancer 29A 13 1820 1823 8260233 10.1016/0959-8049(93)90529-O 1:STN:280: DyaK2c%2FotlWhsw%3D%3D (Pubitemid 23288020)
4. SH Itzkowitz EJ Bloom WA Kokal, et al. 1990 Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients Cancer 66 9 1960 1966 2224793 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3. 0.CO;2-X 1:STN:280:DyaK3M%2FivFWjtw%3D%3D (Pubitemid 20385969)
5. F Guadagni M Roselli M Cosimelli, et al. 1996 Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay Cancer Res 56 22 5293 5298 8912871 1:CAS:528:DyaK28XntFOms7Y%3D (Pubitemid 26383050)
6. M Ghazizadeh H Ogawa Y Sasaki, et al. 1997 Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationships with histopathology and prognosis Hum Pathol 28 8 960 966 9269833 10.1016/S0046-8177(97)90012-5 1:STN:280:DyaK2svhtlCiug%3D%3D (Pubitemid 27355557)
7. H Kobayashi T Terao Y Kawashima 1992 Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer J Clin Oncol 10 1 95 101 1727929 1:STN:280:DyaK38%2Fpt1Sktw%3D%3D
8. SH Cho A Sahin GN Hortobagyi, et al. 1994 Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy Cancer Res 54 24 6302 6305 7987817 1:CAS:528:DyaK2MXislamurg%3D
9. MH Schuessler S Pintado S Welt, et al. 1991 Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer Int J Cancer 47 2 180 187 1988363 10.1002/ijc.2910470204 1:STN:280:DyaK3M7gslWjsQ%3D%3D
10. E Dabelsteen 1996 Cell surface carbohydrates as prognostic markers in human carcinomas J Pathol 179 4 358 369 8869281 10.1002/(SICI)1096-9896(199608) 179:4<358::AID-PATH564>3.0.CO;2-T 1:STN:280:DyaK2s%2Fit12hsw%3D%3D (Pubitemid 26276103)
11. Y Kakeji Y Maehara M Morita, et al. 1995 Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma Br J Cancer 71 1 191 195 7819038 10.1038/bjc.1995.39 1:STN:280:DyaK2M7hvVOqtQ%3D%3D
12. T Nakagoe T Sawai T Tsuji, et al. 2002 Predictive factors for preoperative serum levels of sialyl Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients Anticancer Res 22 1A 451 458 12017332 1:CAS:528:DC%2BD38XktF2mur4%3D (Pubitemid 34475338)
13. S Koga N Kaibara Y Iitsuka, et al. 1984 Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients J Cancer Res Clin Oncol 108 2 236 238 6470030 10.1007/BF00402474 1:STN:280:DyaL2c3ovFKmsw%3D%3D (Pubitemid 14057507)
14. Y Kodera H Nakanishi Y Yamamura, et al. 1998 Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology Int J Cancer 79 4 429 433 9699538 10.1002/(SICI)1097-0215(19980821)79:4<429::AID- IJC20>3.0.CO;2-Z 1:CAS:528:DyaK1cXltVens74%3D (Pubitemid 28359744)
15. H Nakanishi Y Kodera Y Yamamura, et al. 2000 Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the lightcycler Int J Cancer 89 5 411 417 11008202 10.1002/1097-0215(20000920)89:5<411::AID- IJC3>3.0.CO;2-5 1:CAS:528:DC%2BD3cXnsFWmsrg%3D
16. Y Ikehara N Kojima N Kurosawa, et al. 1999 Cloning and expression of a human gene encoding an N-acetylgalactosamine-α2, 6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens Glycobiology 9 11 1213 1224 10536037 10.1093/glycob/9.11.1213 1:CAS:528:DyaK1MXns1emsrw%3D
17. NT Marcos S Pinho C Grandela, et al. 2004 Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen Cancer Res 64 19 7050 7057 15466199 10.1158/0008-5472.CAN-04-1921 1:CAS:528:DC%2BD2cXotFalsb4%3D (Pubitemid 39331016)
18. S Julien MA Krzewinski-Recchi A Harduin-Lepers, et al. 2001 Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc α2, 6-sialyltransferase (ST6GalNAc I) cDNA Glycoconj J 18 11-12 883 893 12820722 10.1023/A:1022200525695 1:CAS:528:DC%2BD3sXotVyrsg%3D%3D (Pubitemid 36315053)
19. I Brockhausen J Yang M Lehotay, et al. 2001 Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression Biol Chem 382 2 219 232 11308020 10.1515/BC.2001.029 1:CAS:528:DC%2BD3MXjtFOjsbg%3D (Pubitemid 32243930)
20. M Clément J Rocher G Loirand, et al. 2004 Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxis J Cell Sci 117 Pt21 5059 5069 15383613 10.1242/jcs.01350 (Pubitemid 39517521)
21. S Pinho NT Marcos B Ferreira, et al. 2007 Biological significance of cancer-associated sialy-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells Cancer Lett 249 2 157 170 16965854 10.1016/j.canlet.2006.08.010 1:CAS:528:DC%2BD2sXjsVektLc%3D (Pubitemid 46452924)
22. S Julien E Adriaenssens K Ottenberg, et al. 2006 ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumorigenicity Glycobiology 16 1 54 64 16135558 10.1093/glycob/cwj033 1:CAS:528:DC%2BD2MXhtlagtbrJ (Pubitemid 43009808)
23. H Nakanishi Y Mochizuki Y Kodera, et al. 2003 Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line Cancer Sci 94 1 112 118 12708484 10.1111/j.1349-7006.2003.tb01361.x 1:CAS:528:DC%2BD3sXisFekuro%3D (Pubitemid 36575868)
24. H Yokoyama H Nakanishi Y Kodera, et al. 2006 Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line Clin Cancer Res 12 2 361 368 16428473 10.1158/1078-0432.CCR-05-1963 1:CAS:528:DC%2BD28XmtlGquw%3D%3D (Pubitemid 43166122)
25. D Colcher PH Hand M Nuti, et al. 1981 A spectrum of monoclonal antibodies reactive with human mammry tumor cells Proc Natl Acad Sci USA 78 5 3199 3203 6789331 10.1073/pnas.78.5.3199 1:STN:280:DyaL3M3kslCnug%3D%3D (Pubitemid 11032016)
26. T Kjeldsen H Clausen S Hirohashi, et al. 1988 Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 α-N-acetylgalactosaminyl (sialosyl-Tn) epitope Cancer Res 48 8 2214 2220 2450649 1:CAS:528:DyaL1cXktVCqtr4%3D
27. S Zhang LA Walberg S Ogata, et al. 1995 Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen Cancer Res 55 15 3364 3368 7614472 1:CAS:528:DyaK2MXnt1ansbs%3D
28. K Denda-Nagai T Irimura 2000 MUC1 in carcinoma-host interactions Glycoconj J 17 7-9 649 658 11421355 10.1023/A:1011039013134 1:CAS:528: DC%2BD3MXksVOgtbw%3D (Pubitemid 32480350)
29. S Nakamori DM Ota KR Cleary, et al. 1994 MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology 106 2 353 361 7905449 1:STN:280:DyaK2c7jtFagsg%3D%3D (Pubitemid 24041211)
30. MD Walsh BG Hohn W Thong, et al. 1994 Mucin expression by transitional cell carcinomas of the bladder Br J Urol 73 3 256 262 8162502 10.1111/j.1464-410X.1994.tb07514.x 1:STN:280:DyaK2c3hsFSlsQ%3D%3D (Pubitemid 24134729)
31. JA Schroeder AA Masri MC Adriance, et al. 2004 MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation Oncogene 23 34 5739 5747 15221004 10.1038/sj.onc.1207713 1:CAS:528: DC%2BD2cXmtVCns7c%3D (Pubitemid 39093019)
32. Y Li D Liu D Chen, et al. 2003 Human DF3/MUC1 carcinoma-associated protein functions as an oncogene Oncogene 22 38 6107 6110 12955090 10.1038/sj.onc.1206732 1:CAS:528:DC%2BD3sXmvFansLg%3D (Pubitemid 37175889)
33. S Satoh Y Hinoda T Hayashi, et al. 2000 Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule Int J Cancer 88 4 507 518 11058865 10.1002/1097-0215(20001115)88: 4<507::AID-IJC1>3.0.CO;2-0 1:CAS:528:DC%2BD3cXotVKitrw%3D
34. J Wesseling SW van der Valk J Hilkens 1996 A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1 Mol Biol Cell 7 4 565 577 8730100 1:CAS:528:DyaK28Xit12qs70%3D (Pubitemid 26112564)
35. MJ Ligtenberg F Buijs HL Vos, et al. 1992 Suppression of cellular aggregation by high levels of episialin Cancer Res 52 8 2318 2324 1559234 1:CAS:528:DyaK38Xitlaqtbg%3D
36. KO Lloyd J Burchell V Kudryashov, et al. 1996 Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells J Biol Chem 271 52 33325 33334 8969192 10.1074/jbc.271.52.33317 1:CAS:528:DyaK2sXitFegtQ%3D%3D (Pubitemid 27010141)
37. MD Burdick A Harris CJ Reid, et al. 1997 Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines J Biol Chem 272 39 24198 24202 9305871 10.1074/jbc.272.39.24198 1:CAS:528:DyaK2sXmsFanu7g%3D (Pubitemid 27418619)
38. L Kinarsky G Suryanarayanan O Prakash, et al. 2003 Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core Glycobiology 13 12 929 939 12925576 10.1093/glycob/cwg109 1:CAS:528:DC%2BD3sXptVeqtbw%3D (Pubitemid 37508896)
39. S Dziadek C Griesinger H Kunz, et al. 2006 Synthesis and structural model of an α(2, 6)-sialyl-T glycosylated MUC1 eicosapeptide under physiological conditions Chem Eur J 12 19 4981 4993 16642533 10.1002/chem.200600144 1:CAS:528:DC%2BD28XmvVaiu70%3D (Pubitemid 43999118)
40. R Marhaba M Zöller 2004 CD44 in cancer progression: adhesion, migration and growth regulation J Mol Histol 35 3 211 231 15339042 10.1023/B:HIJO.0000032354.94213.69 1:CAS:528:DC%2BD2cXltVWqsLg%3D (Pubitemid 40585308)
41. U Günthert M Hofmann W Rudy, et al. 1991 A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell 65 1 13 24 1707342 10.1016/0092-8674(91)90403-L (Pubitemid 121001209)
42. S Seiter R Arch S Reber, et al. 1993 Prevention of tumor metastasis formation by anti-variant CD44 J Exp Med 177 2 443 455 8426113 10.1084/jem.177.2.443 1:CAS:528:DyaK3sXnvV2rsg%3D%3D (Pubitemid 23117094)
43. A Bretscher K Edwards RG Fehon 2002 ERM proteins and merlin: integrators at the cell cortex Natl Rev Mol Cell Biol 3 8 586 599 10.1038/nrm882 1:CAS:528:DC%2BD38XlslGrtbc%3D
44. S Tsukita K Oishi N Sato, et al. 1994 ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons J Cell Biol 126 2 391 401 7518464 10.1083/jcb.126.2.391 1:CAS:528: DyaK2cXltlSktbs%3D (Pubitemid 24226255)
45. S Yonemura M Hirao Y Doi, et al. 1998 Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2 J Cell Biol 140 4 885 895 9472040 10.1083/jcb.140.4.885 1:CAS:528:DyaK1cXhtlegtb4%3D (Pubitemid 28141226)
46. N Labarrière JP Piau C Otry, et al. 1994 H blood group antigen carried by CD44 V modulates tumorigenicity of rat colon carcinoma cells Cancer Res 54 23 6275 6281 7525057 (Pubitemid 24378665)
47. C Goupille F Hallouin K Meflah, et al. 1997 Increase of rat colon carcinoma cells tumorigenicity by α(1-2) fucosyltransferase gene transfection Glycobiology 7 2 221 229 9134429 10.1093/glycob/7.2.221 1:CAS:528:DyaK2sXis1Oms7s%3D (Pubitemid 27168777)